4
Total investments
0
Early stage
0
Mid stage
0
Late stage
22y
Years active
Portfolio
1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Experience · 4 entries
All (4)
Investments (4)
Board (4)
2025
Board Member
Jan 2025
iBio is a cutting-edge biotech company leveraging AI and advanced computational biology to develop next-generation biopharmaceuticals for cardiometabolic diseases, obesity, cancer and other hard-to-treat diseases. By combining proprietary 3D modeling with innovative drug discovery platforms, iBio is creating a pipeline of breakthrough antibody treatments to address significant unmet medical needs. Our mission is to transform drug discovery, accelerate development timelines, and unlock new possibilities in precision medicine. For more information, visit www.ibioinc.com
2014
C
Centro de Diagnóstico y Estudios Metabólicos Avanzados de Cantabria (CDEMAC)
Board Member
May 2014
2005
2004
G
Genetest
Board member
2004
Investment activity
2004–2025 · 4 investments
Recent (last 2 years)Earlier